Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Aukim-Hastie

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Anticancer Research|August 8, 2009
New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA eraBridget Bickers, Claire Aukim-Hastie
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Proteomic evaluation of cancer cells: identification of cell surface proteinsSamantha Larkin, Claire Aukim-Hastie
Methods in Enzymology|June 14, 2014
Study of cellular oncometabolism via multidimensional protein identification technologyClaire Aukim-Hastie, Spiros D Garbis
Expert Review of Proteomics|February 4, 2010
Proteomics in prostate cancer biomarker discoverySamantha E T Larkin, Bashar Zeidan, Matthew G Taylor, et al.
Nature Communications|June 13, 2018
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variantsTokhir Dadaev, Edward J Saunders, Paul J Newcombe, et al.
Nature Genetics|January 10, 2019
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Nature Genetics|June 13, 2018
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Nature Genetics|January 5, 2021
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk predictionDavid V Conti, Burcu F Darst, Lilit C Moss, et al.
Nature Genetics|November 9, 2023
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variantsAnqi Wang, Jiayi Shen, Alex A Rodriguez, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Anticancer Research|August 8, 2009
New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA eraBridget Bickers, Claire Aukim-Hastie
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Proteomic evaluation of cancer cells: identification of cell surface proteinsSamantha Larkin, Claire Aukim-Hastie
Methods in Enzymology|June 14, 2014
Study of cellular oncometabolism via multidimensional protein identification technologyClaire Aukim-Hastie, Spiros D Garbis
Expert Review of Proteomics|February 4, 2010
Proteomics in prostate cancer biomarker discoverySamantha E T Larkin, Bashar Zeidan, Matthew G Taylor, et al.
Nature Communications|June 13, 2018
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variantsTokhir Dadaev, Edward J Saunders, Paul J Newcombe, et al.
Nature Genetics|January 10, 2019
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Nature Genetics|June 13, 2018
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Nature Genetics|January 5, 2021
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk predictionDavid V Conti, Burcu F Darst, Lilit C Moss, et al.
Nature Genetics|November 9, 2023
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variantsAnqi Wang, Jiayi Shen, Alex A Rodriguez, et al.
Pageof 1